Welcome to Francis Academic Press

Academic Journal of Business & Management, 2021, 3(10); doi: 10.25236/AJBM.2021.031004.

Application Risk Supervision Mechanism of Gene Editing Technology


Hechun Wang

Corresponding Author:
Hechun Wang

University of Washington, Washington 98105, USA.


The emergence and application of gene editing technology is one of the important symbols of human social progress, which also means that human beings can gradually treat diseases, eliminate poverty and prolong life by changing genes. However, the application of gold editing technology is in the exploratory stage. In this stage, if we can not establish a sound legislative model and relevant laws and regulations, it will inevitably lead to a series of risks. Therefore, from the perspective of the current application and development of gene editing technology in China, combined with China's basic national conditions, this paper discusses the application risk of gene editing technology in detail, and then puts forward its own views and suggestions on the construction of risk management mechanism of gene editing technology.


Gene editing technology; Genetic engineering; Risk supervision; Ethics

Cite This Paper

Hechun Wang. Application Risk Supervision Mechanism of Gene Editing Technology. Academic Journal of Business & Management (2021) Vol. 3, Issue 10: 23-27. https://doi.org/10.25236/AJBM.2021.031004.


[1] Cohen, I.Glenn, et al. “Gene Editing Sperm and Eggs (Not Embryos): Does It Make a Legal or Ethical Difference?” Journal of Law Medicine & Ethics, vol. 48, no. 3, 2020, pp. 619–621.

[2] Cwik, Bryan P. “Revising, Correcting, and Transferring Genes.” American Journal of Bioethics, vol. 20, no. 8, 2020, pp. 7–18.

[3] Daley, George Q., et al. “After the Storm — A Responsible Path for Genome Editing.” The New England Journal of Medicine, vol. 380, no. 10, 2019, pp. 897–899.

[4] Angrist, Misha, et al. “Reactions to the National Academies/Royal Society Report on Heritable Human Genome Editing.” The CRISPR Journal, vol. 3, no. 5, 2020, pp. 332–349.

[5] Andorno, Roberto, et al. “Geneva Statement on Heritable Human Genome Editing: The Need for Course Correction.” Trends in Biotechnology, vol. 38, no. 4, 2020, pp. 351–354.

[6] Doudna, Jennifer A. “The Promise and Challenge of Therapeutic Genome Editing.” Nature, vol. 578, no. 7794, 2020, pp. 229–236.

[7] Adashi, Eli Y., et al. “Heritable Human Genome Editing: The Public Engagement Imperative.” The CRISPR Journal, vol. 3, no. 6, 2020, pp. 434–439.